Martin Rabellino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martin Rabellino has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Garcia-Monaco
Hospital Italiano de Buenos Aires
4 shared publications Vadim Kotowicz
Servicio de Cirugía Cardiovascular. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
3 shared publications- Daniel Luna
Department of Health Informatics, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
2 shared publications - Ignacio Bluro
Servicio de Cardiología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
2 shared publications José Chas
Servicio de Angiografía y Terapéutica Endovascular; Servicio de Cirugía Cardiovascular. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
2 shared publications- Juan Guido Chiabrando
Interventional Cardiology Unit, UOSD Emodinamica, Ospedale Barone Romeo Patti Italy
2 shared publications
Latest Publications
- 18 March 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 214, 106403
Evolution of artificial intelligence at Hospital Italiano de Buenos Aires: A retrospective review of experience and lessons learned
- 18 March 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 214, 106403
Evolution of artificial intelligence at Hospital Italiano de Buenos Aires: A retrospective review of experience and lessons learned
- Open Access
- 2 July 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
- Vol. 84 (3) , 242-245
Tratamiento endovascular en oclusiones aortoilíacas
Background: Open surgery is the traditional treatment of aortoiliac TASC type C and D lesions. However, as morbidity and mortality rates of open surgery are not negligible, endovascular treatment has emerged as a less invasive option over the last decade. Objective: The aim of this study is to analyze our results with endovascular treatment of these iliac lesions using the primary stenting technique. Methods: We performed a retrospective and descriptive analysis of 32 endovascular interventions for TASC C-D lesions performed from January 2012 to October 2014 to evaluate technical success, perioperative mortality and patency. Results: Technical success was achieved in the 32 (100%) lesions treated. Primary patency was 96.8% after a mean follow-up of 14 months. Cumulative mortality was 6.25% (2 patients) during follow-up. Conclusions: In our experience, endovascular treatment of aortoiliac TASC type C and D lesions is a feasible and safe procedure with a high recanalization rate. Endovascular treatment of this type of lesions could be considered a valid option if these findings are confirmed in large randomized controlled trials comparing this strategy with surgery.
- 2 July 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
- Vol. 84 (3) , 242-245
Open AccessTratamiento endovascular en oclusiones aortoilíacas
Background: Open surgery is the traditional treatment of aortoiliac TASC type C and D lesions. However, as morbidity and mortality rates of open surgery are not negligible, endovascular treatment has emerged as a less invasive option over the last decade. Objective: The aim of this study is to analyze our results with endovascular treatment of these iliac lesions using the primary stenting technique. Methods: We performed a retrospective and descriptive analysis of 32 endovascular interventions for TASC C-D lesions performed from January 2012 to October 2014 to evaluate technical success, perioperative mortality and patency. Results: Technical success was achieved in the 32 (100%) lesions treated. Primary patency was 96.8% after a mean follow-up of 14 months. Cumulative mortality was 6.25% (2 patients) during follow-up. Conclusions: In our experience, endovascular treatment of aortoiliac TASC type C and D lesions is a feasible and safe procedure with a high recanalization rate. Endovascular treatment of this type of lesions could be considered a valid option if these findings are confirmed in large randomized controlled trials comparing this strategy with surgery.
- Open Access
- 10 June 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Resultado clínico del tratamiento endovascular con balón liberador de fármaco en el paciente claudicante con enfermedad femoropoplítea
Background: Restenosis continues to be the great challenge of endovascular therapy, and drug-eluting balloons (DEB) have been developed to reduce it. The aim of this study was to analyze the results of this therapy. Methods: A retrospective analysis of 40 limbs with femoropopliteal lesions treated with DEB was conducted in patients with intermittent claudication. Results: Technical success was obtained in the 40 (100%) limbs treated, without evidence of serious complications related with treatment, and with 92.5% of asymptomatic limbs during the follow-up period of 11.1 months. In three limbs, a new angioplasty was performed due to symptomatic recurrence. Conclusions: The drug-eluting balloon has proven to be a useful, safe and effective tool for the treatment of de novo and in-stent restenosis lesions; however, TASC C-D lesions require the use of greater number of stents.
- 10 June 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessResultado clínico del tratamiento endovascular con balón liberador de fármaco en el paciente claudicante con enfermedad femoropoplítea
Background: Restenosis continues to be the great challenge of endovascular therapy, and drug-eluting balloons (DEB) have been developed to reduce it. The aim of this study was to analyze the results of this therapy. Methods: A retrospective analysis of 40 limbs with femoropopliteal lesions treated with DEB was conducted in patients with intermittent claudication. Results: Technical success was obtained in the 40 (100%) limbs treated, without evidence of serious complications related with treatment, and with 92.5% of asymptomatic limbs during the follow-up period of 11.1 months. In three limbs, a new angioplasty was performed due to symptomatic recurrence. Conclusions: The drug-eluting balloon has proven to be a useful, safe and effective tool for the treatment of de novo and in-stent restenosis lesions; however, TASC C-D lesions require the use of greater number of stents.
- Open Access
- 19 March 2024
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 5 (1) , 22-28
Incidence of endoleak type IA in patients undergoing chimney endovascular aortic repair (ChEVAR) vs. standard endovascular repair
Antecedentes. Aproximadamente la mitad de las reparaciones endovasculares de aneurisma de aorta abdominal (AAA) son realizadas en anatomías hostiles, incrementando el riesgo de complicaciones como endoleaks tipo IA. La técnica con chimeneas (ChEVAR) es una alternativa para disminuir el riesgo de complicaciones en cuellos hostiles. Objetivo: Nuestro objetivo es comparar ambas técnicas (ChEVAR y reparación endovascular convencional [EVAR]) en nuestra medio. Materiales y métodos. Se realizó un trabajo de cohorte retrospectivo en pacientes con AAA tratados con EVAR o ChEVAR. El punto final primario fue la incidencia de endoleak tipo IA. Los puntos finales secundarios fueron la incidencia de oclusión de chimeneas, reintervención, migración, ruptura del saco, isquemia aguda de miembros, crecimiento del saco o mortalidad asociada al aneurisma durante el seguimiento. Resultados. Tras una mediana de seguimiento de 11,5 meses, 79 pacientes fueron tratados con EVAR y 21 con chEVAR. La edad promedio fue de 76,49 ± 7,32 años y 82% fueron de sexo masculino. Los pacientes con chEVAR tuvieron mayor prevalencia de consumo tabáquico que los pacientes con EVAR (38,1% vs. 17,7%, p=0,041) y un cuello más corto (7,88 mm ± 5,73 vs. 36,28 mm ± 13,73, p<0,001). No hubo diferencia de endoleak tipo IA entre los grupos. Dos pacientes presentaron la oclusión total de la chimenea, uno de los cuales requirió reintervención. No hubo diferencias en la regresión del tamaño del saco, así como tampoco hubo eventos de migración, ruptura, isquemia del miembro o mortalidad asociada al aneurisma. Conclusiones. En pacientes con AAA, la técnica ChEVAR en cuellos hostiles tuvo eventos similares que EVAR en cuellos favorables.
- 19 March 2024
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 5 (1) , 22-28
Open AccessIncidence of endoleak type IA in patients undergoing chimney endovascular aortic repair (ChEVAR) vs. standard endovascular repair
Antecedentes. Aproximadamente la mitad de las reparaciones endovasculares de aneurisma de aorta abdominal (AAA) son realizadas en anatomías hostiles, incrementando el riesgo de complicaciones como endoleaks tipo IA. La técnica con chimeneas (ChEVAR) es una alternativa para disminuir el riesgo de complicaciones en cuellos hostiles. Objetivo: Nuestro objetivo es comparar ambas técnicas (ChEVAR y reparación endovascular convencional [EVAR]) en nuestra medio. Materiales y métodos. Se realizó un trabajo de cohorte retrospectivo en pacientes con AAA tratados con EVAR o ChEVAR. El punto final primario fue la incidencia de endoleak tipo IA. Los puntos finales secundarios fueron la incidencia de oclusión de chimeneas, reintervención, migración, ruptura del saco, isquemia aguda de miembros, crecimiento del saco o mortalidad asociada al aneurisma durante el seguimiento. Resultados. Tras una mediana de seguimiento de 11,5 meses, 79 pacientes fueron tratados con EVAR y 21 con chEVAR. La edad promedio fue de 76,49 ± 7,32 años y 82% fueron de sexo masculino. Los pacientes con chEVAR tuvieron mayor prevalencia de consumo tabáquico que los pacientes con EVAR (38,1% vs. 17,7%, p=0,041) y un cuello más corto (7,88 mm ± 5,73 vs. 36,28 mm ± 13,73, p<0,001). No hubo diferencia de endoleak tipo IA entre los grupos. Dos pacientes presentaron la oclusión total de la chimenea, uno de los cuales requirió reintervención. No hubo diferencias en la regresión del tamaño del saco, así como tampoco hubo eventos de migración, ruptura, isquemia del miembro o mortalidad asociada al aneurisma. Conclusiones. En pacientes con AAA, la técnica ChEVAR en cuellos hostiles tuvo eventos similares que EVAR en cuellos favorables.
- Open Access
- 15 February 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (3) , 317-318
The Endovascular Treatment of the Common Femoral Artery Came to Stay: But Which is the Best Option?
- 15 February 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (3) , 317-318
Open AccessThe Endovascular Treatment of the Common Femoral Artery Came to Stay: But Which is the Best Option?
- 28 April 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 55 (6) , 571-576
Common Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patency
Background: Despite considerable morbid-mortality rates, common femoral endarterectomy is still considered the gold standard for atherosclerotic common femoral artery (CFA) disease. The aim of this study was to demonstrate computed tomography angiography based long-term patency after CFA stent placement and to analyze associated risk factors for restenosis. Methods: A retrospective and observational study was carried out in consecutive patients treated with endovascular stent placement in CFA lesions. A clinical follow-up and imaging study was performed using MD-CTA to assess different degrees of in stent restenosis (ISR) and primary, assisted, and secondary patency rates. Results: In a 5-year period, 35 extremities were treated in 33 patients with self-expandable nitinol stents. The technical success was 100% without complications related to the procedure. The mean follow-up (FU) was 32.2 months, and 8 limbs were lost. The degree of CFA stenosis was reduced from 79.69 ± 26.47% to 11.23 ± 24.53%. ISR < 20%, 20–70%, and ≥ 70% was evident in 15 (55.6%), 9 (33.3%), and 3 (11.1%) limbs, respectively. Estimated primary, assisted, and secondary patency was 79.5, 96.3, and 96.3%, respectively, after 24 months and 79.5, 96.3, and 96.3%, respectively after 60 months, with a freedom of clinical driven target lesion revascularisation rate of 87.8%. Conclusion: Endovascular treatment with self-expandable nitinol stents in CFA lesions had a high technical success rate and was related to few complications. A mild form of intimal hyperplasia was observed in a considerable number of cases. However, long-term patency was high; therefore, CFA stent placement might be a suitable therapeutic alternative in selected patients.
- 28 April 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 55 (6) , 571-576
Common Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patency
Background: Despite considerable morbid-mortality rates, common femoral endarterectomy is still considered the gold standard for atherosclerotic common femoral artery (CFA) disease. The aim of this study was to demonstrate computed tomography angiography based long-term patency after CFA stent placement and to analyze associated risk factors for restenosis. Methods: A retrospective and observational study was carried out in consecutive patients treated with endovascular stent placement in CFA lesions. A clinical follow-up and imaging study was performed using MD-CTA to assess different degrees of in stent restenosis (ISR) and primary, assisted, and secondary patency rates. Results: In a 5-year period, 35 extremities were treated in 33 patients with self-expandable nitinol stents. The technical success was 100% without complications related to the procedure. The mean follow-up (FU) was 32.2 months, and 8 limbs were lost. The degree of CFA stenosis was reduced from 79.69 ± 26.47% to 11.23 ± 24.53%. ISR < 20%, 20–70%, and ≥ 70% was evident in 15 (55.6%), 9 (33.3%), and 3 (11.1%) limbs, respectively. Estimated primary, assisted, and secondary patency was 79.5, 96.3, and 96.3%, respectively, after 24 months and 79.5, 96.3, and 96.3%, respectively after 60 months, with a freedom of clinical driven target lesion revascularisation rate of 87.8%. Conclusion: Endovascular treatment with self-expandable nitinol stents in CFA lesions had a high technical success rate and was related to few complications. A mild form of intimal hyperplasia was observed in a considerable number of cases. However, long-term patency was high; therefore, CFA stent placement might be a suitable therapeutic alternative in selected patients.
- 11 February 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 55 (6) , 668-672
Anterograde and Retrograde Approach With Through-and-Through Wiring Technique to Treat a Ruptured and Extremely Tortuous Giant Popoliteal Artery Aneurism
Purpose: This technical note aims to show a challenging endovascular treatment approach of a giant and tortuous ruptured popliteal artery aneurism Materials and Methods: An 86-year-old male patient was admitted for acute lower right limb ischemia. Angio-MSCT showed highly calcified superficial femoral artery, with a 180° bend in distal portion, followed by a large popliteal aneurism (63 × 61 mm) with a large extent hematoma (142 × 112 × 104 mm). Endovascular approach was chosen due to high morbidity. Results: Anterior puncture of right superficial femoral artery was performed under ultrasound guidance. Despite various intents, the 0.035 hydrophilic coated wire could not be crossed distally through the aneurism. Retrograde access was performed via tibio-peroneal trunk under fluoroscopic guidance with a micropuncture set. A stiff 0.035″ Glidewire® was successfully advanced into the proximal portion of the aneurism through a 5F vertebral catheter externalized with a snare from the femoral sheath obtaining a “through-and-through wire” technique. Tightening of both ends of the wire helped gain support and straightened curves. Two stent grafts were implanted with no residual leak at 1 month follow-up. Conclusion: Anterograde and retrograde approach was useful to perform a through-and-through wire technique in a challenging case of a tortuous ruptured popliteal artery aneurism.
- 11 February 2021
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 55 (6) , 668-672
Anterograde and Retrograde Approach With Through-and-Through Wiring Technique to Treat a Ruptured and Extremely Tortuous Giant Popoliteal Artery Aneurism
Purpose: This technical note aims to show a challenging endovascular treatment approach of a giant and tortuous ruptured popliteal artery aneurism Materials and Methods: An 86-year-old male patient was admitted for acute lower right limb ischemia. Angio-MSCT showed highly calcified superficial femoral artery, with a 180° bend in distal portion, followed by a large popliteal aneurism (63 × 61 mm) with a large extent hematoma (142 × 112 × 104 mm). Endovascular approach was chosen due to high morbidity. Results: Anterior puncture of right superficial femoral artery was performed under ultrasound guidance. Despite various intents, the 0.035 hydrophilic coated wire could not be crossed distally through the aneurism. Retrograde access was performed via tibio-peroneal trunk under fluoroscopic guidance with a micropuncture set. A stiff 0.035″ Glidewire® was successfully advanced into the proximal portion of the aneurism through a 5F vertebral catheter externalized with a snare from the femoral sheath obtaining a “through-and-through wire” technique. Tightening of both ends of the wire helped gain support and straightened curves. Two stent grafts were implanted with no residual leak at 1 month follow-up. Conclusion: Anterograde and retrograde approach was useful to perform a through-and-through wire technique in a challenging case of a tortuous ruptured popliteal artery aneurism.
- 5 August 2018
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 52 (8) , 602-606
Symptomatic Iliofemoral and Iliocaval Venous Thrombosis in Patients With Cancer: Endovascular Treatment
Introduction: Proximal (iliocaval and iliofemoral) deep vein thrombosis (DVT) and pulmonary thromboembolism are the second cause of death in patients with cancer. Material and Methods: A retrospective analysis was performed in 35 patients with cancer treated with endovascular therapy for proximal DVT. The primary objective was to evaluate the technical success of the procedure and the 30-day and long-term symptom improvement. Results: Thirty-five patients with a mean age of 57.7 years were treated. In 27 patients, DVT was due to tumor compression and/or invasion of the iliocaval venous axis, and in the remaining 8, it was secondary to their hypercoagulability state. The revascularization techniques used were manual catheter-directed aspiration of the thrombus plus angioplasty and stenting. Technical success was achieved in 33 patients. No complications occurred. Twenty-seven patients were followed up at 30 days posttreatment: 21 were free of postthrombotic syndrome, 4 (14.8%) had mild symptoms, and 2 (7.4%) had moderate symptoms. The mean long-term follow-up was 27.3 months, with a primary patency of 68.8% and assisted and secondary patency rates of 100%. Conclusion: Endovascular revascularization in patients with cancer with extensive and symptomatic proximal DVT is safe and efficient, with a low rate of complications. We consider that this therapy should be offered to patients with cancer with an average or long life expectancy.
- 5 August 2018
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 52 (8) , 602-606
Symptomatic Iliofemoral and Iliocaval Venous Thrombosis in Patients With Cancer: Endovascular Treatment
Introduction: Proximal (iliocaval and iliofemoral) deep vein thrombosis (DVT) and pulmonary thromboembolism are the second cause of death in patients with cancer. Material and Methods: A retrospective analysis was performed in 35 patients with cancer treated with endovascular therapy for proximal DVT. The primary objective was to evaluate the technical success of the procedure and the 30-day and long-term symptom improvement. Results: Thirty-five patients with a mean age of 57.7 years were treated. In 27 patients, DVT was due to tumor compression and/or invasion of the iliocaval venous axis, and in the remaining 8, it was secondary to their hypercoagulability state. The revascularization techniques used were manual catheter-directed aspiration of the thrombus plus angioplasty and stenting. Technical success was achieved in 33 patients. No complications occurred. Twenty-seven patients were followed up at 30 days posttreatment: 21 were free of postthrombotic syndrome, 4 (14.8%) had mild symptoms, and 2 (7.4%) had moderate symptoms. The mean long-term follow-up was 27.3 months, with a primary patency of 68.8% and assisted and secondary patency rates of 100%. Conclusion: Endovascular revascularization in patients with cancer with extensive and symptomatic proximal DVT is safe and efficient, with a low rate of complications. We consider that this therapy should be offered to patients with cancer with an average or long life expectancy.
- 1 May 2017
- Published by Elsevier in Cirugía Española
- Vol. 95 (5) , 298-299
Tratamiento no quirúrgico de seudoaneurisma de la vena cava inferior poshepatectomía
- 1 May 2017
- Published by Elsevier in Cirugía Española
- Vol. 95 (5) , 298-299
Tratamiento no quirúrgico de seudoaneurisma de la vena cava inferior poshepatectomía